N
Patient 1
(B)(4). REPORT SOURCE, FOREIGN, EVENT OCCURRED IN (B)(6). THE DEVICE WAS NOT RETURNED TO THE MANUFACTURER. THEREFORE IT COULD NOT BE ANALYZED. THE REVIEW OF THE DEVICE MANUFACTURING QUALITY RECORD INDICATE THAT 2.615 PRODUCTS DESIGNATION REFOBACIN BONE CEMENT R 40X1, REFERENCE (B)(4), BATCH A750CD0910 WERE MANUFACTURED ON (JULY 16, 2018). THE DEVICE MANUFACTURING QUALITY RECORD ((B)(4)) INDICATES THAT THE RELEASED PRODUCT MET ALL REQUIREMENTS TO PERFORM AS INTENDED. NO NON CONFORMITY OR DEVIATION WAS OBSERVED WHICH COULD BE LINKED TO THE COMPLAINT ISSUE (COMPLAINT CATEGORY INNER STERILE POUCH OPEN SEALING) EVENT DESCRIBED IN THE COMPLAINT. THE DEVICE MANUFACTURING QUALITY RECORD INDICATES THAT THE RELEASED PRODUCT MET ALL REQUIREMENTS TO PERFORM AS INTENDED. ACCORDING TO AVAILABLE DATA, THE MOST PROBABLE ROOT CAUSE IS DUE TO PACKAGING ISSUE (SEALING PROCESS). CORRECTIVE ACTION HAS BEEN INITIATED TO ADDRESS REPORTED ISSUE. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.